These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7833150)

  • 1. Should clinicians be concerned about the carcinogenic potential of tamoxifen?
    Jordan VC; Morrow M
    Eur J Cancer; 1994; 30A(11):1714-21. PubMed ID: 7833150
    [No Abstract]   [Full Text] [Related]  

  • 2. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
    Fisher B; Costantino JP; Redmond CK; Fisher ER; Wickerham DL; Cronin WM
    J Natl Cancer Inst; 1994 Apr; 86(7):527-37. PubMed ID: 8133536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
    Love RR
    J Natl Cancer Inst; 1994 Jul; 86(13):1025-6. PubMed ID: 8007012
    [No Abstract]   [Full Text] [Related]  

  • 4. [Breast cancer, tamoxifen, and uterus].
    Palacios A; Pertusa S; Montoya A; Martínez San Pedro R
    Med Clin (Barc); 1993 Mar; 100(12):479. PubMed ID: 8479228
    [No Abstract]   [Full Text] [Related]  

  • 5. Tamoxifen: trials, tribulations, and trade-offs.
    Friedman MA; Trimble EL; Abrams JS
    J Natl Cancer Inst; 1994 Apr; 86(7):478-9. PubMed ID: 8133527
    [No Abstract]   [Full Text] [Related]  

  • 6. Adducts and tamoxifen.
    Busch H
    Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-98-S1-104. PubMed ID: 9045322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory endometrial adenocarcinoma in a tamoxifen user with breast cancer after menopause.
    Wu CJ; Peng YJ; Yu MH; Chen CH
    Taiwan J Obstet Gynecol; 2007 Mar; 46(1):88-90. PubMed ID: 17389201
    [No Abstract]   [Full Text] [Related]  

  • 8. Dual breast cancers followed by endometrial cancer.
    Dimitrievich E; Sterzinger A
    S D J Med; 2002 Jun; 55(6):227-9. PubMed ID: 12082808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
    Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial cancer and tamoxifen.
    Burke C
    Clin J Oncol Nurs; 2005 Apr; 9(2):247-9. PubMed ID: 15853168
    [No Abstract]   [Full Text] [Related]  

  • 11. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients.
    Robinson DC; Bloss JD; Schiano MA
    Gynecol Oncol; 1995 Nov; 59(2):186-90. PubMed ID: 7590470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group.
    Rutqvist LE; Johansson H; Signomklao T; Johansson U; Fornander T; Wilking N
    J Natl Cancer Inst; 1995 May; 87(9):645-51. PubMed ID: 7752269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of breast cancer by tamoxifen: risks and opportunities.
    Smith LL; Brown K; Carthew P; Lim CK; Martin EA; Styles J; White IN
    Crit Rev Toxicol; 2000 Sep; 30(5):571-94. PubMed ID: 11055836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen mediated human endometrial carcinogenesis may not involve estrogenic pathways: a preliminary note.
    Kuwashima Y; Kurosumi M; Kobayashi Y; Tanuma J; Suemasu K; Higashi Y; Kasamatsu T; Shiromizu K; Matsuzawa M; Kishi K
    Anticancer Res; 1996; 16(5A):2993-6. PubMed ID: 8917418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iatrogenic endometrial megapolyps in women with breast carcinoma.
    Berezowsky J; Chalvardjian A; Murray D
    Obstet Gynecol; 1994 Oct; 84(4 Pt 2):727-30. PubMed ID: 9205466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: second cancers after adjuvant tamoxifen therapy for breast cancer.
    Rutqvist LE
    J Natl Cancer Inst; 1996 Oct; 88(20):1497-9; author reply, 1497-9. PubMed ID: 8841030
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrospray ionization-tandem mass spectrometry and 32P-postlabeling analyses of tamoxifen-DNA adducts in humans.
    Beland FA; Churchwell MI; Doerge DR; Parkin DR; Malejka-Giganti D; Hewer A; Phillips DH; Carmichael PL; Gamboa da Costa G; Marques MM
    J Natl Cancer Inst; 2004 Jul; 96(14):1099-104. PubMed ID: 15265972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tamoxifen dilemma.
    White IN
    Carcinogenesis; 1999 Jul; 20(7):1153-60. PubMed ID: 10383884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.
    Cook LS; Weiss NS; Schwartz SM; White E; McKnight B; Moore DE; Daling JR
    J Natl Cancer Inst; 1995 Sep; 87(18):1359-64. PubMed ID: 7658496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tamoxifen controversy--clinical chemopreventive agent and experimental carcinogen.
    Pitot HC
    Proc Soc Exp Biol Med; 1995 Feb; 208(2):139-40. PubMed ID: 7831344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.